ABSTRACT Background Trimethylamine-N-oxide (TMAO) is a gut microbiota–derived
metabolite produced from dietary nutrients. Many studies have discovered that circulating …

Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiota and has
been mainly associated with an increased incidence of cardiovascular diseases (CVDs) in …

The gut microbiota and its metabolites have become a hotspot of recent research.
Trimethylamine N-oxide (TMAO) metabolized by the gut microbiota is closely related to …

Abstract Background Trimethylamine N-oxide (TMAO) is a metabolite that has attracted
attention due to its positive association with several chronic non-communicable diseases …

Trimethylamine N-oxide (TMAO) is a microbial metabolite derived from nutrients, such as
choline, L-carnitine, ergothioneine and betaine. Recently, it has come under the spotlight for …

Trimethylamine-N-oxide (TMAO) is a gut microbial metabolite that promotes Alzheimer's
disease (AD) progression. Given that probiotics can alleviate AD symptoms by inhibiting the …

Cardiovascular diseases are one of the leading causes of mortality and morbidity worldwide,
with the total number of cases increasing to 523 million in 2019. Despite the advent of new …

Elevated plasma levels of trimethylamine N-oxide (TMAO) have been proposed as a diet-
derived biomarker of cardiometabolic disease risk. Caloric restriction is the most common …

Increasing numerous diabetes annually is a great concern in public health globally. Gut
microbiota recently has been suggested to be an emerging organ acting as a critical …

Numerous nutraceuticals and botanical food supplements are used with the intention of
modulating body weight. A recent review examined the main food supplements used in …